CoChat

Regulation of cyclin D1 expression by mTORC1 signaling requires eukaryotic initiation factor 4E-binding protein 1

Averous, J, Fonseca, B D, Proud, C G · 2008 · Oncogene

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

There is currently substantial interest in the regulation of cell function by mammalian target of rapamycin (mTOR), especially effects linked to the rapamycin-sensitive mTOR complex 1 (mTORC1). Rapamycin induces G(1) arrest and blocks proliferation of many tumor cells, suggesting that the inhibition of mTORC1 signaling may be useful in cancer therapy. In MCF7 breast adenocarcinoma cells, rapamycin decreases levels of cyclin D1, without affecting cytoplasmic levels of its mRNA. In some cell-types, rapamycin does not affect cyclin D1 levels, whereas the starvation for leucine (which impairs mTORC1 signaling more profoundly than rapamycin) does. This pattern correlates with the behavior of eukaryotic initiation factor 4E-binding protein 1 (4E-BP1, an mTORC1 target that regulates translation initiation). siRNA-mediated knock-down of 4E-BP1 abrogates the effect of rapamycin on cyclin D1 expression and increases the polysomal association of the cyclin D1 mRNA. Our data identify 4E-BP1 as a key regulator of cyclin D1 expression, indicate that this effect is not mediated through the changes in cytoplasmic levels of cyclin D1 mRNA and suggest that, in some cell types, interfering with the amino acid input to mTORC1, rather than using rapamycin, may inhibit proliferation.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1210715

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 31 references

Cited by

See all 195

Metadata

Authors
Averous, J., Fonseca, B. D., & Proud, C. G.
Affiliations
University of British Columbia (CA)
Corresponding author
Proud, C G
Venue
Oncogene
Published
2007-08-27
Volume
27
Issue
8
Pages
1106-1113
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2016869069
Cited by
194
References
31
Citations by year
2026: 7 · 2025: 8 · 2024: 11 · 2023: 8 · 2022: 16 · 2021: 10 · 2020: 14 · 2019: 14 · 2018: 13 · 2017: 10 · 2016: 10 · 2015: 11 · 2014: 13 · 2013: 7 · 2012: 9
FWCI
3.69
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Oncogene (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
  • ePrints Soton (University of Southampton) (submittedVersion)
Funders
AstraZeneca
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords
cyclin D1, mTORC1 signaling, 4E-BP1, rapamycin, leucine starvation, mRNA translation, breast cancer, MCF-7 cells, cell proliferation, amino acid signaling
MeSH terms
Mechanistic Target of Rapamycin Complex 1, Antibiotics, Antineoplastic, Breast Neoplasms, Cell Line, Humans, Phosphoproteins, Proteins, Transcription Factors, Signal Transduction, Gene Expression Regulation, Neoplastic, Cell Cycle Proteins, Cyclin D1, Sirolimus, Eukaryotic Initiation Factor-4E, Cell Line, Tumor, Multiprotein Complexes, Adaptor Proteins, Signal Transducing, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Regulation of cyclin D1 expression by mTORC1 signaling requires eukaryotic initiation factor 4E-binding protein 1. https://app.cochat.ai/papers/10.1038/sj.onc.1210715
The paper
Averous, J., Fonseca, B. D., & Proud, C. G. (2008). Regulation of cyclin D1 expression by mTORC1 signaling requires eukaryotic initiation factor 4E-binding protein 1. Oncogene. https://doi.org/10.1038/sj.onc.1210715

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.